François Simondon - Concepedia

Author

François Simondon

Institut de Recherche pour le Développement ORCID

Also Known As

DAVID COURTIN, F SIMONDON, F Simondon, F. SIMONDON, F. Simondon, FRANCOIS SIMONDON, FRANÇOIS SIMONDON, Francois Simondon, François Simondon, FranÇois Simondon

147

Publications

5.9K

Citations

H-Index

118

Concepts

All Affiliations

Institut de Recherche pour le Développement Institut de Recherche pour le Développement Cheikh Anta Diop University MRC Unit the Gambia Statens Serum Institut

About

François Simondon is an author at Institut de Recherche pour le Développement specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	35	2.4K
2	Public Health	19	25	1.2K
3	Education	3	3	262
4	Nursing	2	2	110
5	Engineering	1	1	20

François Simondon

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries Peter Aaby, Badara Samb, François Simondon, BMJ	1995	342
A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal François Simondon, Marie‐Pierre Préziosi, Ablaye Yam, Vaccine VaccinationVaccinologyWhole-cell Pertussis VaccineRandomized Double-blind TrialMedicine	1997	267
Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial Badara Cissé, Cheikh Sokhna, Denis Boulanger, The Lancet MalariaDouble-blind TrialPediatricsSenegalese ChildrenMedicine	2006	213
Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies Peter Aaby, Henrik Jensen, Badara Samb, The Lancet VaccinationEpidemiologyHigh-titre Measles VaccineVaccine EfficacyVaccine Hesitancy	2003	204
Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa Hilton Whittle, Peter Aaby, Badara Samb, The Lancet VaccinologyVaccinationVaccine DevelopmentMedicineImmunology	1999	180
Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria Franck Remoué, Badara Cissé, Fatou Ba, Transactions of the Royal Society of Tropical Medicine and Hygiene Anopheles Salivary AntigensMalariaImmunologyEntomologyAntibody Response	2005	146
Novel Peptide Marker Corresponding to Salivary Protein gSG6 Potentially Identifies Exposure to Anopheles Bites Anne Poinsignon, Sylvie Cornélie, Montserrat Mestres-Simòn, PLoS ONE	2008	131
Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal Badara Samb, Peter Aaby, HILTON C. WHITTLE, The Pediatric Infectious Disease Journal	1995	128
Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa Eve Orlandi‐Pradines, Lionel Alméras, Laurent Denis, Microbes and Infection Saliva AntigensVector-borne PathogenEntomologyImmunologyMalaria	2007	109
Human Antibody Responses to the Anopheles Salivary gSG6-P1 Peptide: A Novel Tool for Evaluating the Efficacy of ITNs in Malaria Vector Control Papa Makhtar Drame, Anne Poinsignon, Patrick Besnard, PLoS ONE Vector ManagementHuman AntibodyMalariaImmunologyParasite Control	2010	105

Page 1